Why the study?
Does intrapericardial OK-432 instillation control effusion in patients with malignant pericardial effusion?
Population
10 patients with malignant pericardial effusion confirmed by cytology
Design
Case_series
Follow-up
average 329 days (range, 54 to 790 days)
Authors
Loading...
Supports OK-432 for malignant effusion control; hypothesis-generating case series requiring randomized confirmation.
Does intrapericardial OK-432 instillation control effusion in patients with malignant pericardial effusion?
Intrapericardial administration of 5 KE of OK-432 appears to be an effective and safe treatment for managing malignant pericardial effusion.
Imamura et al. (1991) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: